WashU Medicine researchers, led by Carlos Cruchaga, have identified biomarkers of Alzheimer’s, Parkinson’s and frontotemporal dementia from blood plasma, suggesting new therapeutic avenues.
Blood plasma reveals shared pathways in neurodegenerative diseases
View Content